Geopacific Resources (ASX:GPR)
In and around Papua New Guinea alone, sit a dozen multi-million once gold projects, ranging in size from 2 million ounces, to over 63 million ounces.
Now, Geopacific Resources (ASX: GPR) has taken a strong foothold in the region as it progressively earns into the Woodlark Project, with a long term goal to transform into a 120koz pa gold producer.
The Woodlark Project has already had over $150 million spent on exploration over the years, and GPR are aiming to increase ore reserves to 1.2 million ounces of gold.
Already excellent assay results are being delivered, however drilling is ongoing, with an RC and two diamond rigs working hard.
As GPR continues its aggressive exploration, it is quickly moving towards recording an updated reserve and rebased feasibility study to be completed in mid-2017, just a few months away now.
The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.
Current drill results continue to return wide sections of continuous grade mineralisation confirming GPR’s re-evaluated geological model.
With a clear path to production, it looks as though GPR could have an early mover advantage in an often overlook region that has abundant gold resources.
GPR Targeting 1.2 Million Ounces in SE Asian Elephant Country
Apr 3, 2017
In the not-so-distant future, Southeast Asia could emerge as one of the most important regions in the global metals industry. So far, the entire region has seen sparse exploration without a ‘mining industry,’ as such, to speak of. That’s about to change courtesy of Geopacific Resources (ASX: GPR) — an Aussie gold explorer that isn’t afraid to take a chance on the promising region.
Related Geopacific Resources (ASX:GPR) articles
Moto went from 4¢ to $4: This ASX Explorer has Same Backer, Same Country, Same Metal… Same Result?
Aug 16, 2019
One ASX Med-Tech is Set to Transform The $100+Billion Cancer Diagnostic Market
Aug 14, 2019